Issue 4, 2016
From the journal:

MedChemComm

Correction: Continuous flow photochemistry as an enabling synthetic technology: synthesis of substituted-6(5H)-phenanthridinones for use as poly(ADP-ribose) polymerase inhibitors

Y. Fanga  and  G. K. Tranmer*ab  

* Corresponding authors

a College of Pharmacy, Faculty of Health Sciences, University of Manitoba, Winnipeg, MB, Canada
E-mail: geoffrey.tranmer@umanitoba.ca

b Department of Chemistry, Faculty of Science, University of Manitoba, Winnipeg, MB, Canada

Abstract

Correction for ‘Continuous flow photochemistry as an enabling synthetic technology: synthesis of substituted-6(5H)-phenanthridinones for use as poly(ADP-ribose) polymerase inhibitors’ by Y. Fang et al., MedChemComm, 2016, DOI: 10.1039/c5md00552c.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C6MD90011A
Article type
Correction
Submitted
23 Feb 2016
Accepted
23 Feb 2016
First published
29 Feb 2016
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2016,7, 732-732

Permissions

Request permissions

Correction: Continuous flow photochemistry as an enabling synthetic technology: synthesis of substituted-6(5H)-phenanthridinones for use as poly(ADP-ribose) polymerase inhibitors

Y. Fang and G. K. Tranmer, Med. Chem. Commun., 2016, 7, 732 DOI: 10.1039/C6MD90011A

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements